National Asset Management, Inc. I Bio, Inc. Transaction History

National Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$1.22 - $1.65 $43,987 - $59,490	-36,055 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.18 - $2.62 $737 - $1,637	625 Added 1.76%	36,055 $56,000
Q4 2020 Feb 04, 2021	BUY	$1.05 - $2.24 $1,711 - $3,651	1,630 Added 4.82%	35,430 $38,000
Q3 2020 Nov 09, 2020	SELL	$1.7 - $6.41 $17,722 - $66,824	-10,425 Reduced 23.57%	33,800 $69,000
Q2 2020 Jul 31, 2020	BUY	$0.87 - $2.46 $38,475 - $108,793	44,225 New	44,225 $99,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.